All In Biotech

Drug Trial Radar · NCT07515014

A Study of E6742 in Participants With Systemic Lupus Erythematosus

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Response Study to Evaluate the Efficacy and Safety of E6742 in Subjects With Systemic Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 256 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

256

Planned (sponsor's estimate)

Start

Mar 31, 2026

Primary completion

Aug 5, 2028

Study completion Mar 1, 2029

Sponsor

Lead sponsor
Eisai Co., Ltd.Eisai
Sponsor type
Industry
First posted
Apr 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of the study is to demonstrate the efficacy based on dose response of E6742 compared with placebo as defined by the proportion of participants achieving a response using the British Isles Lupus Assessment Group (BILAG) based Composite Lupus Assessment (BICLA) with a low dose of oral corticosteroids (OCS) (prednisone or equivalent) at Week 24 in participants with systemic lupus erythematosus (SLE). An Extension Phase of this study will be available to participants that completed Week 24 of the Core Study. All participants in the Extension Phase will receive E6742. There will be no placebo arm during the Extension Phase. The primary purpose of this Extension Phase will be to evaluate the long-term safety and tolerability of E6742 in participants with SLE.

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • E6742Drug

    E6742 oral tablets.

  • PlaceboOther

    Placebo oral tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants who Achieve a BICLA Response with Low Dose of OCS (Prednisone or Equivalent) at Week 24Time frame: At Week 24

Locations

63 sites in 5 countries. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, China · Recruiting

  • Beijing Friendship Hospital, Capital Medical University - PPDS

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital - East Campus

    Beijing, Beijing Municipality, China · Recruiting

  • The Second Affiliated Hospital of Chongqing Medical University - Yuzhong Campus

    Chongqing, Chongqing Municipality, China · Recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China · Not yet recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Nanfang Hospital Southern Medical University - PPDS

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University - North Campus

    Guangzhou, Guangdong, China · Recruiting

  • The Third Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Shantou University Medical College

    Shantou, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China · Recruiting

  • The First Affiliated Hospital of Henan Science and Technology University - Jinghua Campus

    Luoyang, Henan, China · Recruiting

  • Xinxiang Central Hospital

    Xinxiang, Henan, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University - Heyi Campus

    Zhengzhou, Henan, China · Recruiting

  • Yichang Central People's Hospital - Xiling Campus

    Yichang, Hubei, China · Recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • Chenzhou No.1 People's Hospital

    Chenzhou, Hunan, China · Recruiting

  • Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School-Main

    Nanjing, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Soochow University - Pinghailu Campus

    Suzhou, Jiangsu, China · Recruiting

  • The Second Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China · Recruiting

  • Jiujiang No.1 People's Hospital

    Jiujiang, Jiangxi, China · Recruiting

  • The First Affiliated Hospital of Nanchang University - Donghu Campus

    Nanchang, Jiangxi, China · Recruiting

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, China · Recruiting

  • Jilin Province People's Hospital

    Changchun, Jilin, China · Recruiting

  • People's Hospital of Ningxia Hui Aotonomous Region

    Yinchuan, Ningxia, China · Recruiting

  • Linfen Central Hospital

    Linfen, Shanxi, China · Recruiting

  • First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China · Recruiting

  • West China Hospital Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China · Recruiting

  • The Second Affiliated Hospital, Zhejiang University School of Medicine - Jiefanglu Campus

    Hangzhou, Zhejiang, China · Recruiting

  • National Hospital Organization Kyushu Medical Center

    Fukuoka, Japan · Recruiting

  • Hiroshima Prefectural Hospital

    Hiroshima, Japan · Recruiting

  • Kumamoto Shinto General Hospital

    Kumamoto, Japan · Recruiting

  • Niigata University Medical and Dental Hospital

    Niigata, Japan · Recruiting

  • Okayama University Hospital

    Okayama, Japan · Recruiting

  • Daido Clinic

    Nagoya, Aichi-ken, Japan · Recruiting

  • Japan Community Health Care Organization (JCHO) Chukyo Hospital

    Nagoya, Aichi-ken, Japan · Recruiting

  • Fujita Health University Hospital

    Toyoake, Aichi-ken, Japan · Recruiting

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.